The global “non-steroidal anti-inflammatory drugs” market is set to gain momentum from the ever-increasing research activities by several prominent pharmaceutical companies on selective cyclooxygenase-2 inhibitors as they are still a grey area for these companies. Tough, Non-steroidal Anti-Inflammatory Drugs such as ibuprofen and diclofenac are nowadays used to hinder the activity of COX, but they have undesirable effect. Fortune Business Insights™ published this information in a new report, titled, “Non-steroidal Anti-Inflammatory Drugs (Non-steroidal Anti-Inflammatory Drugs) Market Size, Share Industry Analysis, By Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.” The report further mentions that the Non-Steroidal Anti-Inflammatory Drugs market size was USD 15.58 billion in 2019 and is projected to reach USD 24.35 billion by 2027, exhibiting a CAGR of 5.8% during the forecast period.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this Market.
Arthritis Segment to Lead Stoked by Rising Cases of Osteoarthritis
In terms of disease indication, the market is fragmented into ophthalmic diseases, migraine, arthritis, and others. Out of these, the arthritis segment held 37.9% Non-steroidal Anti-Inflammatory Drugs market share in 2019 and is likely to lead throughout the forthcoming years. This growth is attributable to the increasing prevalence of osteoarthritis and rheumatoid arthritis. In addition to that, the rising usage of topical drugs for treating arthritis pain, as well as the increasing geriatric population across the globe would contribute to the growth of this segment.
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune - 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245